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Summary
Objective: Long-term assessment of the effect of hyaluronan (HA) on the articular cartilage and synovium in an animal
knee joint during the development of osteoarthritis (OA).
Design: Sixty mature New Zealand white rabbits underwent unilateral anterior cruciate ligament transection
(ACLT) and were divided into two groups. Group 1 (SA) received intra-articular injections of 0.3 ml hyaluronan (HA)
(i.e., ARTZ, MW: 8 × 105) beginning 4 weeks after ACLT, once a week for 5 weeks. Group 2 (SV) received injections
of the vehicle (phosphate buffered saline) in the same fashion as with the SA group. The contralateral nonoperated
knee served as control. All animals were killed 21 weeks after surgery and their knee joints evaluated by gross
morphologic, histologic, histomorphometric and biochemical analyses.
Results: Gross morphological inspection indicated that the femoral condyles from the knees injected with vehicle
suffered more severe cartilage damage than cartilage from the knees injected with HA. Furthermore, two out of three
histomorphometric parameters measured in the HA-treated cartilage (i.e., cartilage thickness and cartilage area which
were not statistically different than control) provided evidence showing a protective effect of HA on the femoral
condyles following ACLT. Biochemical analysis showed articular cartilage remaining on the femoral condyles
following ACLT to have similar characteristics to contralateral controls. However, DNA concentration in the
synovium from the ACLT knees of the vehicle-treated animals was greater than contralateral control, while this
parameter was not statistically different than contralateral control in the HA treated animals.
Conclusions: These results demonstrate a protective effect of HA on preservation of the articulating surface of the
femoral condyle following ACLT up to 21 weeks post-surgery.
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Introduction
Knee instability following a complete tear of the
anterior cruciate ligament (ACL) often induces
osteoarthritis with accompanying degradation of
the articular cartilage matrix [1–3]. Non-surgical
therapeutic treatment for such a condition has
included, among other treatments, the adminis-
tration of hyaluronan (HA). Several studies have
explored the relationship between HA and syn-
ovial fluid in normal and osteoarthritic joints [4–6],
while a variety of clinical studies have reported on
the relative effectiveness of treatment of osteoar-
thritis (OA) with HA of differing molecular
weights [7–10]. Although little is known of HA’s
in vivo mechanisms in the suppression of the
clinical symptoms of OA, in vitro studies have
shown that HA has the ability to modulate a
variety of cellular functions as well as suppress the
activities of specific pro-inflammatory mediators
[11–13].
Recently several in vivo animal studies have
reported on the early term effectiveness of
HA treatment on experimentally induced osteo-
arthritis [14–18]. In a previous report from this
laboratory, for instance, it was shown that in the
near term, i.e. 9 weeks following ACL transection
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(ACLT), intra-articular injections of HA [molecu-
lar weight (MW) = 8 × 105] were effective in
maintaining specific histomorphometric and bio-
chemical parameters of the articular cartilage
matrix [19]. Because of the reported short half-life
of HA [21, 22], however, a question naturally arose
regarding the effectiveness of HA treatment during
development of osteoarthritis over the long-term.
Therefore, the purpose of the present study was to
carry out a controlled study on the effectiveness of
HA treatment on the suppression of osteoarthritis
over an extended period of time following joint
destabilization. This study assesses the longer term
(21 weeks post-injury) effects of HA on histologic,
histomorphometric and biochemical parameters of
the cartilage matrix following ACLT.
Materials and Methods
experimental design
Sixty mature New Zealand white (NZW) rabbits
underwent unilateral ACLT of the left knees. The
contralateral nonoperated right knees served as
controls. All rabbits were divided into two groups.
Group 1 (SA) received 0.3 ml intra-articular
injections of HA into the left knee 4 weeks after
ACLT, once a week for 5 weeks. Group 2 (SV) was
injected in the same manner with the vehicle
(carrier of HA: sterile phosphate buffered saline).
All animals were killed 21 weeks following surgery
and were then divided into three subgroups for
assessment of knee joints by gross morphologic,
histologic/histomorphometric and biochemical
analyses.
surgery and treatment of animals
All rabbits were anesthetized by intramuscular
injection of ketamine (100 mg/kg) and xylazine
(8 mg/kg). Operative knees were shaved and
disinfected with Betadine solution. A medial
parapatellar incision was made on the skin and a
medial arthrotomy was performed. The patella was
dislocated laterally and the ACL was transected.
The joint was then irrigated with sterile saline and
closed. The capsule was closed with a running
suture of 4-0 prolene and the skin with a running
mattress suture supplemented with interrupted
sutures of 3-0 nylon. Postoperatively the animals
were permitted cage (60 × 60 × 40 cm) activity. The
animals were closely monitored for infections and
other complications.
Four weeks after surgery those rabbits receiving
intra-articular injections of HA or vehicle were
anesthetized with ketamine (30 mg/kg) and xy-
lazine (2 mg/kg). ACLT knees were then shaved
and disinfected with Betadine solution. A 27-gauge
needle on a tuberculin syringe was inserted
beneath the patella in the region of the
patellofemoral joint and 0.3 ml HA or vehicle were
injected. Intra-articular injections were performed
once a week for 5 weeks. All animals were killed
21 weeks following surgery by intracardiac
injection of T-61 euthanasia solution (Fig. 1).
assessment
Gross morphology
Gross morphological changes to the femoral
condyles were assessed as described in a previous
study [19] following the application of india ink.
Histological preparation
In accordance with the results of a previous
study [3] in which the medial femoral condyles
showed the most advanced changes, only medial
femoral condyles were selected for histological
preparation and assessment. Tissue blocks were
fixed in 10% neutral buffered formalin with
cetylpyridinium chloride (CPC) for 7 days and
decalcified with EDTA [22, 23]. After decalcifica-
tion (confirmed by X-ray), the femoral condyles
were cut along the sagittal plane and the medial
condyles were embedded in paraffin. Five micron
sections were cut with a Reichert–Jung microtome
and stained with safranin O/fast green.
The synovium from the ACLT and contralateral
knees of each group was also processed, embedded
in paraffin and stained with hematoxylin and eosin
(H & E) for cellular assessment by image analysis.
Histomorphometry
The histological sections were visualized and
assessed using a color image analysis system
(Oncor instrument systems, U.S.A.) with micro-
scope (Nikon Microphot, Japan) and high-resol-
ution color video camera (Hitachi HV-C10, Japan).
Video images were captured by a high-
definition video processing board in the image
analysis system computer (Everex 486/25, U.S.A.).
Fig. 1. Surgery and treatment protocol: time scale. ( )
OA development; (,) treatment; (q) observation.
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Images were viewed on a high-resolution color
monitor (Sony Trinitron, Japan). Customized
image analysis software measured the following
geometric parameters: (1) thickness, (2) area, (3)
surface roughness, and (4) thickness of synovial
lining cell layer.
The geometric parameters of the cartilage were
measured on a condylar weight-bearing area of
7 mm length at ×32 magnification. The thickness
of cartilage from the surface to the tide mark was
calculated from the mean of five measurements
made perpendicular to the surface of each section
at five equally spaced points along the 7 mm
length. The area of the cartilage present between
the monitor screen edges (7 mm) was also
calculated. The thickness and area of cartilage
were also computed using a mathematical algor-
ithm and employing the coordinates of the
articular cartilage and tidemark. Calculation of
the cartilage surface roughness is based on the
deviations from an idealized smooth surface [19]
and is expressed as the root mean square (RMS)
surface roughness.
Inflammation/cellular proliferation of synovial
tissue was assessed by measuring the thickness of
the synovial lining cell layer. This thickness was
determined by averaging the measured thickness
at 100 different locations along the length of the
histological specimen.
biochemistry
Water content
Immediately after death the articular cartilage
was dissected from the femoral condyles of the
ACLT and contralateral control knees, placed into
preweighed vials and weighed again to an
accuracy of 0.1 mg. The samples were then
lyophilized and reweighed for determination of
water content.
Non-reducible collagen cross-links (pyridinoline)
concentration
The concentration of the non-reducible collagen
cross-link hydroxypyridinium contained in the
articular cartilage was determined by reverse-
phase high-performance liquid chromatography
(HPLC) [24]. Five milligrams (dry) of tissue were
hydrolyzed in 6 n HCl overnight at 108°C.
Following desiccation, the hydrolysate was redis-
solved in 1% heptafluorobutyric acid and the
cross-link hydroxypyridinium was isolated by
HPLC on a reversed-phase column (ODS, C-18;
Beckman Instruments U.S.A.). Elution was by a
gradient of acetonitrile (12–18%) in 0.01 m hep-
tafluorobutyric acid. Monitoring and quantitation
of hydroxypyridinium was achieved by in-line
fluorescence (ex. = 297 nm, em. = 390 nm). The stan-
dard employed was pyridoxamine, which has
identical spectral characteristics with hydrox-
ypyridinium. Results are expressed as equivalent
moles of pyridoxamine per mole of collagen.
Hexosamine concentration
Total hexosamine content in the tissue was
determined by colorimetry [24]. Three to 5 mg of
lyophilized cartilage were hydrolyzed in 1 ml of 6 n
HCl for 5 h at 100°C. The acid hydrolysates were
desiccated and hexosamine quantitation was
achieved by a modified Elson–Morgan reaction.
The results are expressed as micrograms of amino
sugar per milligram of dry tissue.
DNA concentration in synovial tissue
Synovial tissue cellularity was assessed by
quantitating the tissue concentration of DNA
according to the procedure of Bonting and Jones
as modified by Amiel et al. [24]. Seven to 10 mg H2O
washed and lyophilized tissue were solubilized by
incubation for 2 h in 3.0 ml of 1 n NaOH at 65°C.
Duplicate 1.0 ml aliquots were reacted with 0.04%
indole–HCl reagent and mixed with chloroform to
remove interfering substances. The aqueous phase
containing the DNA was removed and the
absorbance was read at 490 nm. Standards of calf
thymus DNA were also determined for comparison.
Results are expressed as microgram DNA per
milligram of dry tissue.
statistical analysis
All data are presented as mean 2 standard
deviation and were subjected to statistical analysis
using analysis of variance (ANOVA) with paired
data sets, with a level of significance set at a = 0.05.
Results
gross morphology
Femoral condyle
Figures 2(a) and (b) illustrate visually the result
of ACLT on the femoral condyles from the SA and
SV groups, respectively. Osteophytes on the medial
condyles were observed to be generally more
prominent with a corresponding increase in
severity of cartilage damage. Gross morphological
grading of cartilage damage was performed on the
medial femoral condyles and the results are
illustrated in Fig. 3. Various grades of OA were
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Fig. 2: Gross morphology of the femoral condyles. (a)
ACLT knee: grade 3 OA specimen from the SA group.
Overt fibrillation is seen on the medial condyle (white
arrows). (b) ACLT knee: grade 4c OA specimen from the
SV group. Full-thickness ulceration is seen on the
medial condyle (closed white arrow) along with overt
fibrillation on the lateral condyle (open arrows). (c)
Specimen of contralateral control condyle. Smooth
cartilage surface shows normal appearance.
changes except for one condyle which had grade 2
fibrillation.
Synovium
Thickening of the synovium relative to con-
tralateral control was observed in all of the ACLT
knees; there were no obvious differences in
synovial hypertrophy between the SA and SV
groups.
qualitative histological evaluation
Femoral condyle
Histological evidence for cartilage degeneration
(surface roughness and loss of safranin/O staining)
was observed in the ACLT knees of both SA and
SV groups. However, there appeared to be a
rougher cartilage surface and less uniform
safranin/O staining in the condyles from the SV
group than in the condyles from the SA group. The
contralateral condyles demonstrated a mostly
normal histological appearance. Representative
histological assessment is illustrated in Fig. 4a–c.
Synovium
Hyperplasia of the synovial lining cell layer was
observed in the ACLT knees from both the SA and
SV groups, with the SV synovia demonstrating
slightly greater hyperplasia than the SA synovia
(Fig. 5).
histomorphometry—quantitative analysis
Cartilage thickness and area
Statistically significant decreases (relative to
contralateral controls) in cartilage thickness and
Fig. 3. Gross morphological assessment of the femoral
condyles from SA and SV groups (N = 10 each). Note that
the extent and grade of cartilage damage in the condyles
from the ACLT knees in SA group was less severe than
in the SV group.
observed in the ACLT knees from both groups;
however the severity of damage was generally
greater in the SV group compared with the SA
group. Whereas in the SA group only one condyle
out of 10 evaluated showed grade 4c cartilage
surface damage, five condyles in the SV group
demonstrated grade 4c damage. The contralateral
condyles gave no evidence of osteoarthritic
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Fig. 4. Histological evaluation (Safranin O/fast green) of
the femoralcondyles. (a) ACLT specimen from the SA
group (original magnification × 30). Irregularity of the
cartilage surface is seen in accordance with the loss of
Safranin O stain. (b) ACLT specimen from the SV group
(original magnification × 30). Cartilage thickness is
decreased with severe fibrillation. Ulceration of the
cartilage exposing the smooth surface of the subchon-
dral bone is seen. (c) Contralateral control specimen
(original magnification × 30). Cartilage matrix was
consistently well-stained with Safranin O.
Cartilage surface roughness
In the SV group, surface roughness of the
femoral condyle cartilage from the ACLT knees
was statistically greater than contralateral
control while this parameter was not significantly
different from control in the SA group. These
results are shown in Fig. 6(c).
Fig. 5. Histological evaluation (H&E) of synovium. (a)
ACLT knee specimen from the SA group (original
magnification × 93). Hyperplasia of synovial lining cell
layer was seen in part (white arrow). (b) ACLT knee
specimen from the SV group (original magnifi-
cation × 93). Hyperplasia of synovial lining cells is
marked (white arrow). (c) Contralateral control knee
specimen (original magnification × 93). Proliferation of
the synovial lining cell layer is minimal.
area were observed in the ACLT knees from the SV
group. Cartilage thickness and area were not
statistically different from controls in the SA
group. These data are illustrated in Fig. 6(a) and
(b).
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Fig. 6. Histomorphometric analysis of the medial femoral condyles from HA and vehicle treated knees. All data
expressed as mean 2 standard deviation. (a) Cartilage thickness: N = 10; *P Q 0.05. (b) Cartilage area: N = 10; *P Q 0.05.
(c) Cartilage roughness: N = 10; *P Q 0.05. (d) Thickness of synovial lining cell layer: N = 10; *P Q 0.05. (Q) ACLT; ( )
Control.
Thickness of the synovial lining cell layer
Thickness of the ACLT synovial lining cell layer
in the SA and SV groups was significantly greater
than their respective contralateral controls. This
parameter is shown in Fig. 6(d).
biochemistry
Water content
The water content of the ACLT cartilage from
the femoral condyle in the SA and SV groups
was similar to their respective controls, i.e.,
near-normal values with no statistically significant
differences observed [Fig. 7(a)].
Pyridinoline concentration
In the SA and SV groups no significant
differences in pyridinoline concentration were
observed in the femoral condyle cartilage from
the ACLT knees relative to their respective
contralateral controls [Fig. 7(b)].
Hexosamine concentration
The hexosamine concentrations of the femoral
cartilage in the ACLT knees were not statistically
different than their respective control values. This
was true for both SA and SV groups [Fig. 7(c)].
DNA concentration in synovium
In the SA group no statistically significant
difference in DNA content was observed in the
synovium from the ACLT knees relative to
contralateral control. However, in the SV group,
the DNA concentration in the synovium was
significantly higher than its contralateral control.
These results are illustrated in Fig. 7(d).
Discussion
Joint destabilization secondary to a complete
tear of the ACL is known to cause a breakdown of
the articulating surfaces in those joints with the
resulting loss of joint function [1–3]. In a previous
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study we showed that in the short-term (following
ACLT), HA had beneficial effects in preserving
assessments of the articular cartilage and syn-
ovium were carried out. Since these assessments
were made immediately after the end of HA
treatment, it was important to address whether
HA, in the ACLT model, might have longer-term
beneficial effects on the articular cartilage and
synovium of the injured joints. In the present study
we report that HA, despite its reported short
half-life [20, 21], slowed progression of OA in the
articular cartilage and synovium 12 weeks after
cessation of treatment. Morphological grading of
the femoral condyles revealed that the extent and
severity of cartilage damage was less in the HA
treated than in the vehicle treated knees.
Furthermore, histomorphometric analysis showed
that cartilage thickness, area and roughness in the
vehicle treated knees were all statistically inferior
to their contralateral controls, while these par-
ameters in the HA treated knees were not
significantly different than controls.
The results of biochemical analysis of the
articular cartilage were less conclusive. There was
an apparent discrepancy between the hexosamine
concentration [Fig. 7(c)] data and the safranin O
staining shown in Fig. 4. The examples of safranin
O stained sections include a ‘good’ HA-treated
specimen and a ‘poor’ vehicle-treated specimen.
These results varied somewhat from specimen to
specimen, although morphological grading showed
that overall the HA-treated cartilage suffered less
severe changes than the vehicle-treated cartilage.
The hexosamine data, on the other hand, is a mean
from 10 specimens in each group, and these results
showed that, on average, no difference between
groups could be established. Also, no differences
between ACLT cartilage and contralateral control
cartilage were seen in either treatment group for
the other biochemical parameters. There was,
Fig. 7. Biochemical analysis of the medial femoral condyles from HA andvehicle treated knees. All data expressed as
mean 2 standard deviation. (a) Water content in the articular cartilage. N = 10. (b) Pyridinoline concentration in the
articular cartilage: N = 10. (c) Hexosamine concentration in the articular cartilage: N = 10. (d) DNA concentration in
the synovium: N = 10; *P Q 0.05. (Q) ACLT; ( ) Control.
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however, an inherent problem in the biochemical
evaluation since the analyses were made on the
specific histomorphometric and biochemical par-
ameters of the articular cartilage and synovium in
the affected joints [19]. In that study the animals
were killed immediately after HA treatment and
histologic, histomorphometric and biochemical
cartilage remaining following cartilage loss over
the 21-week post-ACLT period. Thus, the biochemi-
cal characteristics of the ACLT cartilage in the
two treatment groups might appear similar to their
contralateral controls and to each other even
while actual loss of cartilage surface was greater
in one group compared with the other. Indeed,
the morphological and histomorphometric data
revealed greater degeneration of the vehicle
treated ACLT cartilage than HA treated ACLT
cartilage.
In this long-term study the most prominent
biochemical difference was that the DNA concen-
tration in the ACLT synovium from the vehicle-
treated knee was statistically higher than its
contralateral control (indicating synovial inflam-
mation), while this parameter was similar to
control in the HA treated synovium. This was
consistent with the histological (H & E) obser-
vation that synovial hyperplasia appeared
more pronounced in the SV group than in the
SA group. From these data we can postulate
an anti-inflammatory effect of HA on the rabbit
knee joint 12 weeks after the end of treatment.
This conclusion is supported by the findings of
Yasui [25] and Aihara [26] who demonstrated a
reduced level of prostaglandin E2 PGE2 and
bradykinin in the synovial joint following HA
injection.
In terms of the direct effect of exogenous HA
on the articular cartilage matrix components,
Yasui et al. [6] showed in an in vitro study that
the addition of HA stimulates TIMP-1 production
in bovine articular chondrocytes. The feedback
mechanism of exogenous HA in the synovial
joint, as postulated by Iwata [27], strongly
supports the concept of upregulation of the
endogenous HA since the half-life of exogenously
administered HA was shown to be no more than
22 h [20].
In summary, the morphologic, histomorphomet-
ric and biochemical results of this long-term
study indicate that HA has a protective effect
on the articular cartilage up to 21-weeks post-
ACLT. To our knowledge this is the first study
to establish such long-term in vivo beneficial
effects of exogenous HA on the preservation of
articular cartilage and synovium following joint
destabilization in an animal model.
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